COMPOSITIONS HAVING ENHANCED PHARMACOKINETIC CHARACTERISTICS

摘要

Compositions comprising a therapeutic component and an efficacy enhancing component, that enhances the pharmacokinetic disposition of the therapeutic component, are disclosed. The therapeutic component may include an alpha-2- adrenergic agonist and the efficacy enhancing component may include fatty acids. In one embodiment, the therapeutic component and the efficacy enhanci ng component form a complex.